PMID- 25811991 OWN - NLM STAT- MEDLINE DCOM- 20160328 LR - 20181113 IS - 1528-3658 (Electronic) IS - 1076-1551 (Print) IS - 1076-1551 (Linking) VI - 21 IP - 1 DP - 2015 Mar 23 TI - Human Parthenogenetic Embryonic Stem Cell-Derived Neural Stem Cells Express HLA-G and Show Unique Resistance to NK Cell-Mediated Killing. PG - 185-96 LID - 10.2119/molmed.2014.00188 [doi] AB - Parent-of-origin imprints have been implicated in the regulation of neural differentiation and brain development. Previously we have shown that, despite the lack of a paternal genome, human parthenogenetic (PG) embryonic stem cells (hESCs) can form proliferating neural stem cells (NSCs) that are capable of differentiation into physiologically functional neurons while maintaining allele-specific expression of imprinted genes. Since biparental ("normal") hESC-derived NSCs (N NSCs) are targeted by immune cells, we characterized the immunogenicity of PG NSCs. Flow cytometry and immunocytochemistry revealed that both N NSCs and PG NSCs exhibited surface expression of human leukocyte antigen (HLA) class I but not HLA-DR molecules. Functional analyses using an in vitro mixed lymphocyte reaction assay resulted in less proliferation of peripheral blood mononuclear cells (PBMC) with PG compared with N NSCs. In addition, natural killer (NK) cells cytolyzed PG less than N NSCs. At a molecular level, expression analyses of immune regulatory factors revealed higher HLA-G levels in PG compared with N NSCs. In line with this finding, MIR152, which represses HLA-G expression, is less transcribed in PG compared with N cells. Blockage of HLA-G receptors ILT2 and KIR2DL4 on natural killer cell leukemia (NKL) cells increased cytolysis of PG NSCs. Together this indicates that PG NSCs have unique immunological properties due to elevated HLA-G expression. FAU - Schmitt, Jessica AU - Schmitt J AD - Institute for Medical Radiology and Cell Research (MSZ) in the Center for Experimental Molecular Medicine (ZEMM), University of Wurzburg, Wurzburg, Germany. FAU - Eckardt, Sigrid AU - Eckardt S AD - Center for Molecular and Human Genetics, The Research Institute at Nationwide Children's Hospital, Columbus, Ohio, United States of America. FAU - Schlegel, Paul G AU - Schlegel PG AD - University Children's Hospital Wurzburg, Pediatric Hematology/Oncology, Wurzburg, Germany. FAU - Siren, Anna-Leena AU - Siren AL AD - Department of Neurosurgery, Section for Experimental Tumor Immunology, University of Wurzburg, Wurzburg, Germany. FAU - Bruttel, Valentin S AU - Bruttel VS AD - University of Wurzburg Medical School, Department of Obstetrics and Gynecology, Section for Experimental Tumor Immunology, University of Wurzburg, Wurzburg, Germany. FAU - McLaughlin, K John AU - McLaughlin KJ AD - Center for Molecular and Human Genetics, The Research Institute at Nationwide Children's Hospital, Columbus, Ohio, United States of America. FAU - Wischhusen, Jorg AU - Wischhusen J AD - University of Wurzburg Medical School, Department of Obstetrics and Gynecology, Section for Experimental Tumor Immunology, University of Wurzburg, Wurzburg, Germany. FAU - Muller, Albrecht M AU - Muller AM AD - Institute for Medical Radiology and Cell Research (MSZ) in the Center for Experimental Molecular Medicine (ZEMM), University of Wurzburg, Wurzburg, Germany. LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20150323 PL - England TA - Mol Med JT - Molecular medicine (Cambridge, Mass.) JID - 9501023 RN - 0 (HLA-DR Antigens) RN - 0 (HLA-G Antigens) RN - 0 (MIRN152 microRNA, human) RN - 0 (MicroRNAs) SB - IM MH - Apoptosis/genetics/immunology MH - *Cell Differentiation MH - Cell Line MH - *Cytotoxicity, Immunologic MH - Embryonic Stem Cells/*cytology MH - *Gene Expression MH - Gene Expression Regulation MH - HLA-DR Antigens/genetics/immunology/metabolism MH - HLA-G Antigens/*genetics/immunology/metabolism MH - Humans MH - Killer Cells, Natural/*immunology/metabolism MH - MicroRNAs/genetics MH - Neural Stem Cells/cytology/*immunology/*metabolism PMC - PMC4503648 EDAT- 2015/03/27 06:00 MHDA- 2016/03/29 06:00 PMCR- 2015/03/23 CRDT- 2015/03/27 06:00 PHST- 2014/09/20 00:00 [received] PHST- 2015/03/23 00:00 [accepted] PHST- 2015/03/27 06:00 [entrez] PHST- 2015/03/27 06:00 [pubmed] PHST- 2016/03/29 06:00 [medline] PHST- 2015/03/23 00:00 [pmc-release] AID - molmed.2014.00188 [pii] AID - 14_188_schmitt [pii] AID - 10.2119/molmed.2014.00188 [doi] PST - epublish SO - Mol Med. 2015 Mar 23;21(1):185-96. doi: 10.2119/molmed.2014.00188.